BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15658303)

  • 1. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():349-53. PubMed ID: 15035150
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM
    Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
    Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
    Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
    [No Abstract]   [Full Text] [Related]  

  • 6. Tartrate-resistant acid phosphatase as a serum marker of bone resorption.
    Halleen JM; Ranta R
    Am Clin Lab; 2001 Jul; 20(6):29-30. PubMed ID: 11480390
    [No Abstract]   [Full Text] [Related]  

  • 7. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
    Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)].
    Stejskal D; Zurek M; Svecová R; Zapletalová J; Bartek J; Oral I; Horalík D; Lacnák B; Jedelský L; Lenobelová H
    Vnitr Lek; 2001 Jan; 47(1):60-2. PubMed ID: 15635870
    [No Abstract]   [Full Text] [Related]  

  • 9. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
    Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA
    Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
    Uchida K; Nakanishi M; Yoh K
    Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
    Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
    J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
    Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
    J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B; Caffier H; Sütterlin MW; Dietl J
    Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
    Janckila AJ; Yam LT
    Calcif Tissue Int; 2009 Dec; 85(6):465-83. PubMed ID: 19915788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process.
    Toussirot E; Dumoulin G; Saas P; Nguyen NU; Le Huédé G; Wendling D
    Ann Rheum Dis; 2008 Mar; 67(3):430-1. PubMed ID: 18292108
    [No Abstract]   [Full Text] [Related]  

  • 16. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
    Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE
    Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
    Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
    Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of bone turnover: biochemical and clinical perspectives.
    Pagani F; Francucci CM; Moro L
    J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.